skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 713  for All Library Resources

previous page 1 Results 2 3 4 5 next page
Refined by: Database: Taylor & Francis Open Access remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Usefulness of insertable cardiac monitors for risk stratification: current indications and clinical evidence
Material Type:
Article
Add to My Research

Usefulness of insertable cardiac monitors for risk stratification: current indications and clinical evidence

Expert review of medical devices, 2023-02, Vol.20 (2), p.85-97 [Peer Reviewed Journal]

2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;ISSN: 1743-4440 ;EISSN: 1745-2422 ;DOI: 10.1080/17434440.2023.2171862 ;PMID: 36695092

Digital Resources/Online E-Resources

22
Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
Material Type:
Article
Add to My Research

Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.1169-1184 [Peer Reviewed Journal]

2021 Huang et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Huang et al. 2021 Huang et al. ;ISSN: 1178-7066 ;EISSN: 1178-7066 ;DOI: 10.2147/PGPM.S323379 ;PMID: 34557019

Full text available

23
Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review
Material Type:
Article
Add to My Research

Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review

Annals of medicine (Helsinki), 2016-10, Vol.48 (7), p.496-508 [Peer Reviewed Journal]

2016 Informa UK Limited, trading as Taylor & Francis Group 2016 ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2016.1187764 ;PMID: 27460395

Digital Resources/Online E-Resources

24
Fruit vinegars attenuate cardiac injury via anti-inflammatory and anti-adiposity actions in high-fat diet-induced obese rats
Material Type:
Article
Add to My Research

Fruit vinegars attenuate cardiac injury via anti-inflammatory and anti-adiposity actions in high-fat diet-induced obese rats

Pharmaceutical biology, 2017-01, Vol.55 (1), p.43-52 [Peer Reviewed Journal]

2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2016 ;2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/Licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2016 The Author(s). ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2016.1226369 ;PMID: 27595296

Full text available

25
Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report
Material Type:
Article
Add to My Research

Extracorporeal Membrane Oxygenation in Septic Cardiomyopathy Caused by Aspergillus Infection: The First Case Report

Infection and drug resistance, 2024-01, Vol.17, p.1303-1307 [Peer Reviewed Journal]

2024 Wu et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;2024 Wu et al. 2024 Wu et al. ;ISSN: 1178-6973 ;EISSN: 1178-6973 ;DOI: 10.2147/IDR.S449491 ;PMID: 38576823

Full text available

26
Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions
Material Type:
Article
Add to My Research

Review of Mavacamten for Obstructive Hypertrophic Cardiomyopathy and Future Directions

Drug design, development and therapy, 2023-01, Vol.17, p.1097-1106 [Peer Reviewed Journal]

2023 Dong et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023 Dong et al. 2023 Dong et al. ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/DDDT.S368590 ;PMID: 37064432

Full text available

27
Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy

Amyloid, 2017-04, Vol.24 (2), p.87-91 [Peer Reviewed Journal]

2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2017 ;ISSN: 1350-6129 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2017.1322573 ;PMID: 28475415

Digital Resources/Online E-Resources

28
Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry
Material Type:
Article
Add to My Research

Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry

Scandinavian cardiovascular journal : SCJ, 2020-07, Vol.54 (4), p.239 [Peer Reviewed Journal]

ISSN: 1651-2006 ;EISSN: 1651-2006 ;DOI: 10.1080/14017431.2020.1727000 ;PMID: 32054352

Digital Resources/Online E-Resources

29
Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy
Material Type:
Article
Add to My Research

Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy

Scandinavian cardiovascular journal : SCJ, 2014-08, Vol.48 (4), p.202 [Peer Reviewed Journal]

EISSN: 1651-2006 ;DOI: 10.3109/14017431.2014.932922 ;PMID: 24912526

Digital Resources/Online E-Resources

30
Diagnosis and Screening of Patients with Fabry Disease
Material Type:
Article
Add to My Research

Diagnosis and Screening of Patients with Fabry Disease

Therapeutics and clinical risk management, 2020-01, Vol.16, p.551-558 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Vardarli et al. 2020 Vardarli et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S247814 ;PMID: 32606714

Full text available

31
Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy
Material Type:
Article
Add to My Research

Assessing the relationship between systemic immune-inflammation index and mortality in patients with hypertrophic cardiomyopathy

Upsala journal of medical sciences, 2021, Vol.126, p.e8124-9 [Peer Reviewed Journal]

2021 The Author(s). Published by Upsala Medical Society. ;Publisher changed from Taylor & Francis, Ltd. © 2021. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Upsala Medical Society. 2021 ;ISSN: 0300-9734 ;EISSN: 2000-1967 ;DOI: 10.48101/ujms.v126.8124 ;PMID: 34984097

Full text available

32
Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres
Material Type:
Article
Add to My Research

Peripartum cardiomyopathy in Turkey: Experience of three tertiary centres

Journal of obstetrics and gynaecology, 2016-07, Vol.36 (5), p.574-580 [Peer Reviewed Journal]

2016 Informa UK Limited, trading as Taylor & Francis Group 2016 ;ISSN: 0144-3615 ;EISSN: 1364-6893 ;DOI: 10.3109/01443615.2015.1107531 ;PMID: 26789488 ;CODEN: JOGYDW

Digital Resources/Online E-Resources

33
Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies
Material Type:
Article
Add to My Research

Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies

Autoimmunity (Chur, Switzerland), 2008-01, Vol.41 (6), p.442-453 [Peer Reviewed Journal]

2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008 ;2008 Informa UK Ltd. 2008 ;ISSN: 0891-6934 ;EISSN: 1607-842X ;DOI: 10.1080/08916930802031579 ;PMID: 18781470

Digital Resources/Online E-Resources

34
Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 10
Material Type:
Article
Add to My Research

Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 10

Channels (Austin, Tex.), 2024-12, Vol.18 (1), p.2355121-2355121 [Peer Reviewed Journal]

EISSN: 1933-6969 ;DOI: 10.1080/19336950.2024.2355121 ;PMID: 38762910

Full text available

35
Exploration and validation of signature genes and immune associations in septic cardiomyopathy
Material Type:
Article
Add to My Research

Exploration and validation of signature genes and immune associations in septic cardiomyopathy

Clinical and experimental hypertension (1993), 2024-12, Vol.46 (1), p.2302570-2302570 [Peer Reviewed Journal]

ISSN: 1064-1963 ;EISSN: 1525-6006 ;DOI: 10.1080/10641963.2024.2302570 ;PMID: 38281072

Full text available

36
Knockdown of lectin-like oxidized low-density lipoprotein-1 ameliorates alcoholic cardiomyopathy via inactivating the p38 mitogen-activated protein kinase pathway
Material Type:
Article
Add to My Research

Knockdown of lectin-like oxidized low-density lipoprotein-1 ameliorates alcoholic cardiomyopathy via inactivating the p38 mitogen-activated protein kinase pathway

Bioengineered, 2022-04, Vol.13 (4), p.8926-8936 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 2165-5979 ;EISSN: 2165-5987 ;DOI: 10.1080/21655979.2022.2056814 ;PMID: 35333694

Full text available

37
Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis
Material Type:
Article
Add to My Research

Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis

Pharmacogenomics and personalized medicine, 2021-01, Vol.14, p.823-837 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Ma et al. 2021 Ma et al. ;ISSN: 1178-7066 ;EISSN: 1178-7066 ;DOI: 10.2147/PGPM.S314880 ;PMID: 34285551

Full text available

38
Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
Material Type:
Article
Add to My Research

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

Vascular health and risk management, 2010-01, Vol.6 (default), p.593-601 [Peer Reviewed Journal]

2010. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2010 Muratore and Baranchuk, publisher and licensee Dove Medical Press Ltd. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s8355 ;PMID: 20730015

Full text available

39
Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy
Material Type:
Article
Add to My Research

Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapy

Application of clinical genetics, 2014-01, Vol.7 (default), p.195-208 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Roma-Rodrigues and Fernandes. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1178-704X ;EISSN: 1178-704X ;DOI: 10.2147/TACG.S49126 ;PMID: 25328416

Full text available

40
Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes
Material Type:
Article
Add to My Research

Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes

Clinical epidemiology, 2017-01, Vol.9, p.403-410 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Magnusson et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/CLEP.S139300 ;PMID: 28848363

Full text available

Results 21 - 40 of 713  for All Library Resources

previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1991  (12)
  2. 1991 To 1999  (30)
  3. 2000 To 2007  (67)
  4. 2008 To 2016  (224)
  5. After 2016  (380)
  6. More options open sub menu

Resource Type 

  1. Articles  (679)
  2. Reports  (32)
  3. Conference Proceedings  (2)
  4. More options open sub menu

Language 

  1. Japanese  (57)
  2. Norwegian  (2)
  3. More options open sub menu

Searching Remote Databases, Please Wait